PharmatrophiX Obtains $10,300,000 New Funding Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7e698b05-ff59-4ccd-a7d2-964032855b69
Date 11/23/2015
Company Name PharmatrophiX
Mailing Address 2300 Wells Fargo Capitol Center Raleigh, NC 27601 USA
Company Description PharmatrophiX is a biotech working on drugs that prevent neurodegenerative disease. Founded by Stanford researcher Frank Longo, PharmatrophiX is developing a class of drugs that mimic the activity of proteins called neurotrophins, which aid in the development, health and survival of neurons.
Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.